The present invention relates to formulations for delivery of drugs to the respiratory tract, especially the lungs, as well as improved methods of treating subjects suffering or predisposed to suffering from lung conditions/diseases. The invention is particularly directed to lung cancer treatment using, for example, cytotoxic platinum based drugs.
|Publication status||Published - 30 Dec 2009|
- drug delivery
- non-ionic surfactants